Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 8.01 · 8-K

Regen Biopharma, Inc.

RGBPOTCEQUITYCurrent

Other Events

Item 8.01 Other Events. On January 19, 2026 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of February 3, 2026 (“Record Date”) to be paid to shareholders on or about February 9, 2026 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of one share of Series A Preferred St…

Filed Jan 21, 2026Accepted Jan 21, 2026, 1:01 AM ESTCIK 1589150Accession 0001493152-26-002956
Share

Company context

Current securities

Recent company filings

  1. 10-Q filingAug 17, 2026
  2. NT 10-Q filingAug 13, 2026
  3. Entry into a Material Definitive Agreement · Changes in Registrant's Certifying Accountant · Other EventsJul 15, 2026
  4. 10-Q filingMay 14, 2026
  5. Unregistered Sales of Equity SecuritiesMar 4, 2026

Disclosure sections

Items 8.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On January 19, 2026 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of February 3, 2026 (“Record Date”) to be paid to shareholders on or about February 9, 2026 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of one share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date.